Characterization of pulmonary hypertension (PH) and the effects of myectomy in hypertrophic cardiomyopathy (HCM) remain poorly defined. The aim of the study was to investigate the effect of myectomy on PH in HCM.
Introduction
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, characterized by cardiac hypertrophy in the absence of an identifiable haemodynamic aetiology. 1, 2 Patients exhibit diverse clinical phenotype, ranging from asymptomatic to sudden cardiac death (SCD) or medically refractory symptoms necessitating septal reduction therapy.
Although much attention has focused on the left-sided pathophysiology, alterations in pulmonary haemodynamics may also be evident.
Pulmonary hypertension (PH) in HCM may be secondary to elevation of left-sided diastolic pressures (due to diastolic dysfunction, the contraction load associated with obstruction, or via systolic anterior motion-mediated mitral regurgitation) or from a primary pulmonary vascular process or a combination of both. Although PH is a known adverse short-and long-term prognosticator in a variety of cardiac pathologies, little is known about its potential modification by septal reduction therapy in patients with HCM. 3 -5 Accordingly, we sought to analyse the effect of myectomy on pulmonary haemodynamics.
Methods

Patient selection
This retrospective analysis consisted of adult patients with clinically and echocardiographically confirmed HCM evaluated at the Mayo Clinic (Rochester, MN, USA) between January 2004 and December 2010 who underwent surgical myectomy. The diagnosis of HCM was based on the presence of myocardial hypertrophy in the absence of local or systemic aetiologies. 1, 6, 7 Transthoracic echocardiography inclusive of quantification of right ventricular systolic pressure (RVSP) was obtained within 1 month preceding myectomy and before hospital dismissal in all patients. During this time period, 988 patients underwent myectomy; patients without a sufficient tricuspid regurgitation signal for echocardiographic estimation of RVSP at either study were excluded. When available, retrospective review of subsequent echocardiographic follow-up (.20 days post-operative) inclusive of RVSP estimation was performed for all included study patients. Informed consent was obtained for the use of patient medical records for research purposes in accordance with Minnesota law, and an Institutional Review Board approved the study. When clinically indicated, patients had a collection of plasma BNP by fluorescence immunoassay (Biosite Diagnostics, San Diego, CA, USA) or plasma NT-Pro BNP measured via electrochemiluminescence immunoassay (Roche Diagnostics, Indianapolis, IN, USA) as previously described. 8, 9 Symptom-limited graded exercise testing was performed using a motor-driven treadmill (Quinton, Seattle, WA, USA) with an accelerated Naughton protocol. Continuous electrocardiographic monitoring (Marquette Electronics, Milwaukee, WI, USA) and breath-to-breath metabolic measurement (Medical Graphics, St Paul, MN, USA) were utilized as previously described. 10 
Echocardiographic evaluation
The presence of a comprehensive two-dimensional transthoracic echocardiographic examination constituted an inclusion criterion to enter the study. Left ventricular cavity size, LV mass, wall thickness, and ejection fraction were determined in the standard fashion. 11 Left atrial volume index was calculated by either the prolate ellipse or biplane arealength method. 12 Mitral inflow velocity curves (peak early diastolic velocity [E] and peak late diastolic velocity [A]) and annular tissue Doppler signals (medial e ′ and lateral e ′ ) were obtained as previously described. 13 All echocardiographic data were averaged from three to five end-expiratory cycles. Measurement of the resting LV outflow tract gradient was performed by continuous-wave Doppler interrogation of the LV outflow tract from an apical window and calculated using the modified Bernoulli equation (i.e. gradient ¼ 4v LVOT 2 , where v LVOT is peak LV outflow tract velocity).
Right ventricular systolic pressure was determined in a standard fashion per ASE guidelines.
14 Specifically, pressure was calculated using the modified Bernoulli equation, as the sum of the estimated right atrial pressure and 4v TR 2 , where v TR is the peak tricuspid regurgitant velocity.
Right ventricular systolic pressure cut-offs of 35 and 50 mmHg were utilized as previously described, 15 with PH defined as an RVSP of ≥35 mmHg and moderate or severe PH defined as an RVSP of ≥50 mmHg. Estimated right atrial pressure was nominally classified into 5, 10, 14, or 20 mmHg, primarily on the basis of inferior vena cava size and degree of inspiratory collapse.
Data analysis
Continuous variables are expressed as median with interquartile range. Correlations of continuous variables were examined using simple linear regression analysis or Wilcoxon rank-sum test as appropriate. Student's t-tests, Pearson x 2 analyses, and Fisher exact tests were used as appropriate. Paired t-tests were used to assess differences in serial RVSP measures. Survival was assessed using Kaplan -Meier survival analysis, with log-rank test P-values reported. Statistical significance was set a priori at P , 0.05. All analyses were performed using JMP version 9.0 (SAS Institute, Inc., Cary, NC, USA).
Results
Study population
Three hundred and six patients met the study inclusion criteria and 67 patients had a subsequent echocardiogram at least 20 days after their post-myectomy study for assessment. Patient demographics are listed in Table 1 Table 2 . Patients with moderate or severe PH were more likely to require intraoperative blood products and had longer length of stay.
The median study follow-up was 3.1 (IQR 0.2 -5.0) years, with 3-year survival 97.5% (95% confidence interval 94.1-99.0%). There was no significant difference in survival between patients with preoperative moderate or severe PH and those with normal preoperative pulmonary pressures (log-rank P ¼ 0.5).
Echocardiographic assessment
The results of pre-myectomy echocardiographic assessment are given in Table 3 . Median RVSP was 36 (IQR 30 -44) mmHg. One hundred and fortyfive patients (47%) had no evidence of PH (RVSP , 35 mmHg), 110 patients (36%) had mild PH (RVSP 35-50 mmHg), and 51 patients (17%) had moderate or severe PH (RVSP ≥50 mmHg; range 50-128 mmHg). Estimated right atrial pressure was 5 (IQR 5-10) mmHg. Left ventricular outflow tract gradient was higher in patients with moderate or severe PH when compared with those with normal pulmonary pressures, as was the presence of resting obstruction, despite the fact that septal thickness and LV mass did not differ ( Right ventricular systolic pressure following myectomy 
Predictors of right ventricular systolic pressure reduction with myectomy
In patients with PH, significant correlates for decrease in RVSP from pre-myectomy to late assessment were higher left atrial volume index (R ¼ 0.43, P ¼ 0.0069) and moderate or severe mitral regurgitation (R ¼ 0.33, P ¼ 0.038). The only significant pre-myectomy predictor of improvement in RVSP at the time of hospital dismissal was 
Discussion
The present investigation demonstrates that surgical myectomy results in favourable reductions in PH. This reduction is most prominent in patients with moderate or severe PH, with evidence of progressive decline in the cohort with long-term follow-up. Clinical variables associated with decline in PH were higher left atrial volume index, LV outflow tract gradient, and presence of moderate or severe mitral regurgitation. These data have important implications for PH in HCM, which thus far has not been well studied in this patient population.
There is a paucity literature assessing PH in HCM. In our population, 53% of patients were noted to have PH (RVSP ≥35 mmHg), with a significant cohort (17%) having moderate or severe PH (RVSP ≥50 mmHg). Patients with significant PH differed substantially in regard to multiple demographic, echocardiographic, and cardiopulmonary exercise findings in comparison to patients with normal pulmonary pressures (Tables 1 and 3) . Pulmonary hypertension is known to have female predominance outside of HCM, considered to be associated with altered levels of oestrogen, differential signalling, and altered metabolism of oestrogens; 16 our findings suggest that this relationship with sex extends to patients with HCM. Furthermore, older female patients were disproportionately affected by PH. This age-dependent finding suggests a post-capillary aetiology of PH related to a combination of age-dependent myocardial stiffening and time-dependent exposure to alterations in haemodynamic loading conditions such as obstruction, mitral regurgitation, and diastolic dysfunction. There may also be a reactive pulmonary vascular component secondary to the long-standing elevation of left atrial pressure, similar to mitral stenosis, which occurs more commonly in older women. 17 Non-invasive indices of diastolic function revealed significant preoperative differences between patients with significant PH and those without. Medial and lateral E/e ′ ratios were higher in PH patients compared with those with normal RVSP. We have previously published a modest correlation in HCM between the E/e ′ ratio and simultaneous invasive haemodynamic filling pressure assessment, 18 and the present data would suggest higher filling pressures in the PH group. Concomitant shorter deceleration times, larger left atria, and more pronounced early diastolic filling on mitral inflow interrogation are all consistent with diastolic dysfunction in the PH cohort. These data imply a post-capillary aetiology of PH, and our data demonstrating reduction in pulmonary pressures following myectomy, which improves ventricular haemodynamics and reduction of obstruction-associated mitral regurgitation, further support this explanation. Improvement in PH at hospital discharge was most prominent in those with moderate or severe PH ( Figure 1A) , with 65% of patients demonstrating a reduction of at least 10 mmHg. This improvement continued at late follow-up, albeit in a smaller cohort (Figure 2) . While some reduction in RVSP at initial follow-up may be attributed to acute procedure-associated fluid shifts, the persistence of decline and further reduction at subsequent follow-up suggests that there was an additional pulmonary vascular component to the PH. Because a pre-hospital dismissal echocardiogram was a pre-requisite for study inclusion, this study may not accurately represent early post-operative mortality; however, prior data from our institution demonstrates early mortality rates of ,1%. 19, 20 Patients with PH had longer length of stay (median difference 1 day) and were more likely to require intraoperative blood products, data consistent with an overall sicker population. However, our data suggest that PH in HCM should not be a contraindication to myectomy, and to the contrary that myectomy may provide improvement in pulmonary haemodynamics in addition to systemic haemodynamics and symptoms. Furthermore, our findings describe key echocardiographic determinants of improvement in PH. Initial benefit in pulmonary haemodynamics from myectomy appears to be secondary to improvement in filling haemodynamics (positive correlation with left atrial volume index) and this relationship persisted at long-term evaluation. Significant pre-myectomy mitral regurgitation was also a key predictor of long-term improvement of PH. Myectomy alleviates systolic anterior motion of the mitral valve mediated mitral regurgitation, and the improvement of PH with elimination of mitral regurgitation implies the pulmonary haemodynamic insult of mitral regurgitation is a key underlying component of PH aetiology in HCM. Moreover, post-hospital improvement in PH correlated with pre-myectomy resting LV outflow tract gradient, suggesting a distinct effect from relief of obstruction. These data may help guide clinicians considering myectomy in HCM patients with PH.
Our findings are in concert with a previously published smaller study by Stone et al., 4 who assessed 49 HCM patients with preoperative pulmonary systolic pressures .35 mmHg undergoing myectomy. They demonstrated a 40% reduction in pulmonary systolic pressure (62 + 3 to 38 + 2 mmHg, P , 0.0001) with associated fall in pulmonary capillary wedge pressure (24 + 1 to 16+ 5 mmHg, P ¼ 0.0002). As with our study, patients with more severe PH had the greatest improvement in pulmonary haemodynamics. 4 However, this study did not compare HCM patient with PH with those without, nor did it discuss pre-operative predictors of improvement in PH. In our study, there was no difference in survival between patients with moderate or severe pre-myectomy PH and those with normal pre-operative pulmonary pressures. This lack of difference may be attributed to sample size and length of follow-up, or alternatively myectomy and its associated reduction in RVSP may obviate a component of mortality risk. Our findings raise interesting questions for further research into the natural history of PH within HCM. If patients with moderate or severe PH have significantly higher mortality in the absence of myectomy, our data could provide an impetus for earlier myectomy in patients with less severe symptoms. Conversely, if there is no real difference in outcome between patients with and without PH, this would strongly support the existing recommendation to intervene only in the presence of severe, medically refractory symptoms.
Study limitations
The present study is a retrospective analysis, with known inherent limitations, including selection bias. Patients who did not have sufficient tricuspid regurgitation for RVSP assessment at pre-and postoperative evaluation were excluded and this is a potential source of error. While serial RVSP measures provide longitudinal assessment of pulmonary haemodynamics, there is risk of false-positive results with multiple testing. Assessment of PH within this study was based on echocardiographic data and not right heart catheterization. Invasive pulmonary vascular resistance was not utilized to characterize PH in individual patients and this is a potential area for future study. However, utilization of serial RVSP assessment has the advantage of being a non-invasive, internally controlled measure to follow pulmonary haemodynamics.
Conclusions
In summary, demographic and echocardiographic characteristics in symptomatic HCM patients with PH differ significantly from those without PH. Septal reduction therapy leads to a long-term significant decrease in RVSP, most prominent in patients with moderate or severe PH. Patients with enlarged left atria and moderate or severe mitral regurgitation tended to have the greatest improvement in PH.
